Nephros (NEPH)
Medical and commercial point-of-use filtration for water-management applications.
Something off on this page? Send us feedback.
Medical infection-control and dialysis-water filters sit alongside commercial filtration products for foodservice equipment and ice machines. The business combines a hollow-fiber water-technology base with a dialysis-market heritage.
Medical products span infection-control microfilters and ultrafilters, plus dialysis-water filters. Commercial water-filtration products include carbon-based and carbon-free offerings for foodservice equipment and ice machines.
Rooted in hollow-fiber water technology and a dialysis-market heritage, the business addresses proactive and emergency water management in medical and commercial settings. It also provides water-quality education as part of its offering. Operations are based in South Orange, New Jersey.
Medical product claims are FDA-regulated, and dialysis-filter models are FDA 510(k)-cleared. The business depends on continuing product performance and manufacturing arrangements across medical and commercial applications.
Company facts
Categories
Target rangeAs of Sep 2, 2026
Latest analyst notes
| Date | Firm | Action | Target |
|---|---|---|---|
| Jul 17, 2026 | Northland Securities | Target | $4 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $4.7M · Total debt $872.0K · Total assets $15.8M · Shareholders' equity $12.0M
- Revenue
- $6.0M
- Operating income
- $1.2M
- Net income
- $1.2M
No dividends on record.
| Institutions27 holders · as of Mar 31, 2026 | 49.45% | 5.37M shares | |
| Insiders8 holders · as of Aug 14, 2026 | 18.58% | 2.02M shares | |
| Otherremainder | 31.97% | 3.47M shares |
10.86M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Wexford Capital LPInstitution | 33.15% | 3.60M | 13Fas of Mar 31, 2026 |
Topline Capital Management, LLCInstitution | 5.36% | 581,967 | 13Fas of Mar 31, 2026 |
Cowen Prime Advisors, a division of Cowen Prime Services LLCInstitution | 5.30% | 575,077 | 13Gfiled Jan 27, 2021 ↗ |
Ian CasselInsider | 4.84% | 525,408 | 13Gfiled Feb 28, 2022 ↗ |
Sandra F. PessinInsider | 4.51% | 489,435 | 13D/Afiled Oct 21, 2020 ↗ |
| See all 25 → | |||
13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more
Insider tradesForm 4
No open-market trades in the last 12 months.
- Danaher
Medical point-of-use filters for healthcare water safety
- Solventum
Commercial foodservice and drinking-water filtration
- Pentair
Commercial water filtration for foodservice equipment
- Watts Water Technologies
Commercial filters and treatment for foodservice water
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Nephros | $4.26 | +3.90% | $45.8M | 26.6 | 22.8 | 2.2 | +36.2% |
| Danaher | $209.13 | −0.37% | $147.59B | 37.3 | 23.6 | 5.9 | +5.5% |
| Solventum | $91.90 | −0.01% | $15.91B | 11.2 | 13.6 | 1.9 | +2.2% |
| Pentair | $60.00 | +0.25% | $9.55B | 15.0 | 12.3 | 2.4 | −17.0% |
| Watts Water Technologies | $351.84 | −0.11% | $11.75B | 30.7 | 26.4 | 4.4 | +18.6% |
| Median | 22.9 | 18.6 | 3.4 | +3.9% |